Literature DB >> 9049205

Epithelial-mesenchymal transition of cultured rat neonatal hepatocytes is differentially regulated in response to epidermal growth factor and dimethyl sulfoxide.

R Pagan1, I Martín, M Llobera, S Vilaró.   

Abstract

Neonatal rat hepatocytes cultured in the absence of added growth factors dedifferentiate by epithelial-mesenchymal transition (EMT). This involves the loss of their typical differentiation markers, the acquisition of a migrating morphology, and a change in the expression of the intermediate filament (IF) proteins. We attempted to determine whether the EMT of cultured neonatal rat hepatocytes could be modulated by factors that maintain and promote the differentiation state of adult and fetal hepatocytes such as epidermal growth factor (EGF) and dimethyl sulfoxide (DMSO). By (3H)-thymidine incorporation, Western blotting analysis, flow cytometry, and double-immunofluorescence studies, we found that both factors have marked but opposite effects on the EMT and on proliferation of neonatal liver cells. In DMSO treatment, albumin levels were higher than in the nontreated cells at all days studied. Moreover, DMSO reduced cytokeratin levels and inhibited cell proliferation, acquisition of the fibroblast-like morphology, and vimentin expression typical of the EMT. The increase in vimentin-positive cells in serum-free medium was not observed in DMSO cultures. EGF also increased albumin levels at all days studied. In contrast, EGF treatment induced hepatocyte proliferation and enhanced vimentin and cytokeratin expression. However, the increase in vimentin levels did not correlate with a significant increase in the number of vimentin-positive cells. Moreover, vimentin-positive cells in EGF treatment were also cytokeratin-positive and albumin-positive, and they maintained epithelioid morphology in spite of the vimentin network. These results indicate that EMT of cultured rat neonatal hepatocytes is differentially regulated in response to EGF and DMSO.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049205     DOI: 10.1002/hep.510250318

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

Review 1.  Wound healing in the liver with particular reference to stem cells.

Authors:  M Alison; M Golding; C Sarraf
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

Review 2.  Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).

Authors:  A S Martínez-Ramírez; M Díaz-Muñoz; A Butanda-Ochoa; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2016-11-29       Impact factor: 3.765

3.  Dimethyl sulfoxide and oxidative stress on cultures of human keratinocytes.

Authors:  Ivone da Silva Duarte; Alfredo Gragnani; Lydia Masako Ferreira
Journal:  Can J Plast Surg       Date:  2004

4.  Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways.

Authors:  Lee A Borthwick; Aaron Gardner; Anthony De Soyza; Derek A Mann; Andrew J Fisher
Journal:  Cancer Microenviron       Date:  2011-07-27

5.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

Authors:  Jing-Lin Xia; Chunsun Dai; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 6.  Hepatic regeneration and the epithelial to mesenchymal transition.

Authors:  Zeng-Fu Xue; Xiu-Min Wu; Ming Liu
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

7.  Epithelial-mesenchymal transition in liver fibrosis.

Authors:  Ya-Lei Zhao; Rong-Tao Zhu; Yu-Ling Sun
Journal:  Biomed Rep       Date:  2016-01-25

Review 8.  Epithelial-to-mesenchymal transitions in the liver.

Authors:  Steve S Choi; Anna Mae Diehl
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

9.  Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine.

Authors:  Daniela Gordillo-Bastidas; Edén Oceguera-Contreras; Adriana Salazar-Montes; Jaime González-Cuevas; Luis Daniel Hernández-Ortega; Juan Armendáriz-Borunda
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

10.  Local control of hepatic phenotype with growth factor-encoded surfaces.

Authors:  Dipali Patel; Amranul Haque; Caroline N Jones; Nazgul Tuleouva; Elena Foster; Tam Vu; A Hari Reddi; Alexander Revzin
Journal:  Integr Biol (Camb)       Date:  2014-01       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.